Collegium Pharmaceutical, Inc. COLL Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s net income?
- Collegium Pharmaceutical, Inc. (COLL) reported net income of $14.5M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s net income changed year-over-year?
- Collegium Pharmaceutical, Inc.'s net income increased by 499.8% year-over-year, from $2.42M to $14.5M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s net income?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s net income has grown at a -3.2% compound annual growth rate (CAGR), from $71.52M to $62.87M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.